2.84
2.84 (0%)
As of Feb 14, 2025
Biocardia, Inc. [BCDA]
Source:
Company Overview
Biocardia, Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs.
| Country | United States |
| Headquarters | sunnyvale, california |
| Phone Number | (650) 226-0120 |
| Industry | manufacturing |
| CEO | Peter Altman, Ph.D. |
| Website | www.biocardia.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-8 |
| Net Income | $-7.9 |
| Net Cash | $1.3 |
Profit Ratios
| Gross Margin | $0.1 |
| Operating Margin | -13,794.8 |
| Profit as % of Revenues | -0.7% |
| Profit as % of Assets | -236.8% |
| Profit as % of Stockholder Equity | -949.3% |
Management Effectiveness
| Return on Equity | -949.3% |
| Return on Assets | -213.4% |
| Turnover Ratio | 1.7% |
| EBITA | $-8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $3.7 |
| Total Liabilities | $2.9 |
| Operating Cash Flow | $-8 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $9.3 |
